Previous Article | Next Article ![]()
Infect. Immun., 06 1996, 1900-1905, Vol 64, No. 6
D Chen, JC McMichael, KR VanDerMeid, D Hahn, T Mininni, J Cowell and J Eldridge
Moraxella catarrhalis causes otitis media, laryngitis, and respiratory
infections in humans. A high-molecular-weight outer membrane protein from
this bacterium named ubiquitous surface protein A (UspA) is present on all
isolates. A monoclonal antibody (MAb) to UspA that recognizes a conserved
epitope of this protein has been shown to promote pulmonary clearance of
bacteria in passively immunized mice. In the present study, M. catarrhalis
heterologous isolates were screened by dot blot with a panel of four
additional MAbs specific for surface- exposed epitopes of UspA from M.
catarrhalis isolate 035E. Three of the MAbs were specific for 035E, and the
fourth reacted with 17 (74%) of the 23 isolates tested. Thus, UspA contains
highly conserved, semiconserved, and variable surface-exposed epitopes. The
UspA was purified from the 035E isolate by ion-exchange and size-exclusion
chromatography, formulated with the adjuvant QS-21, and used to immunize
BALB/c mice. Upon pulmonary challenge with either 035E or the heterologous
isolate TTA24, significantly fewer bacteria were recovered from the lungs
of immunized mice 6 h postchallenge than from control mice. The immune sera
from mice or guinea pigs contained high titers of antibodies to the
homologous isolate and heterologous isolates in a whole-bacterial-cell
enzyme-linked immunosorbent assay. Sera against UspA, whether prepared in
mice or guinea pigs, had complement-dependent bactericidal activity toward
homologous and 11 heterologous M. catarrhalis isolates. These results
indicate that the conserved epitopes of the UspA are highly immunogenic and
elicit broadly reactive and biologically functional antibodies. UspA may
offer protection against M. catarrhalis infections and is being further
evaluated as a vaccine candidate.
Copyright © 1996, American Society for Microbiology
Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization
Lederle-Praxis Biologicals, West Henrietta, New York 14586-9728, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|